Mark E. Hensley - 06 May 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role: Chief Operating Officer
Signature: /s/Kathryn Lester Attorney-in-fact for Mark E. Hensley
Issuer symbol: HRTX
Transactions as of: 06 May 2025
Net transactions value: $0
Form type: 4
Filing time: 07 May 2025, 12:20:50 UTC
Previous filing: 29 Apr 2025
Next filing: 03 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hensley Mark Earl	Chief Operating Officer	100 REGENCY FOREST DRIVE, SUITE 300, CARY	/s/Kathryn Lester Attorney-in-fact for Mark E. Hensley	07 May 2025	0002065816

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRTX	Restricted Stock Units	Award	$0	+500,000		$0.000000	500,000	06 May 2025	Common Stock	500,000	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installmens thereafter.